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Since 1989~we have confirmed the diagnosis of human ehrlichiosis in 57 patients. Although routine radiological studies of the central nervous system (CNS) or analyses of cerebrospinal fluid (CSF) samples were not done for these patients, primary care physicians detected symptoms or signs that prompted them to perform such studies. CSF samples were examined for 15 of the 57 patients. Findings in eight of the 15 CSF samples were abnormal, and the most common abnormalities were lymphocytic pleocytosis and elevated protein levels. A search of the English-language literature revealed 21 additional cases in which CSF examinations were performed; in 13 of these cases, CSF findings were abnormal. The most common clinical finding that predicted CSF abnormalities was a change in mental status. A total of 14 patients underwent computerized tomographic studies, and none of these studies showed abnormalities. Four (19%) of the 21 patients with CNS manifestations of ehrlichiosis and abnormal CSF findings died.
Human infection with Ehrlichia was first reported in the United States in 1987 [1] . In 1991~an organism isolated from the blood of a patient was characterized and designated as a new Ehrlichia species, E. chaffeensis [2, 3] . More recently, Bakken et al. [4, 5] have described cases of human infection due to an Ehrlichia species that is closely related to Ehrlichia equi/Ehrlichia phagocytophila [4, 5] . Both agents parasitize WBCs. E. chaffeensis tends to parasitize mononuclear cells, while the agent described by Bakken et al. parasitizes granulocytic leukocytes. Both agents are thought to be tick borne and produce a nonspecific clinical syndrome characterized by fever, headache, myalgias, arthralgias, and other symptoms; these symptoms are associated with laboratory findings that include leukopenia, thrombocytopenia, and abnormal liver function [4] [5] [6] [7] .
We and other investigators have noted that CNS manifestations occur in --20% of patients infected with E. chaffeensis [6, 7] . Seventeen percent of the patients with human granulocytic ehrlichiosis (HGE) were reported to have confusion [5] , and evidence of meningitis has been cited in several reports [1, [8] [9] [10] [11] [12] [13] [14] . We describe our experience with patients who had CNS involvement during episodes of ehrlichiosis, and we review the English-language literature on this condition.
Methods
We gathered data from the records for a previously reported series of patients seen by the infectious diseases consultative services at the University of Missouri Hospitals (Columbia, MO) and the Harry S. Truman Veterans Affairs Hospital (Columbia) during the period 1989 through 1993 [5] and for subsequent patients seen through September 1995. We also reviewed previously published cases in which CSF examinations were done [1, 5, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . CSF was considered to be abnormal when any of the following values were obtained: leukocyte count, >5 X 10 6 fL; protein level, >0.45 g/L; or glucose concentration, <2.5 mmol/L.
Routine lumbar puncture or other procedures for studying CNS were not part of our prospective study and were done at the discretion of primary care physicians. Data on neurological symptoms and the results of radiological studies and CSF examinations were abstracted from the patients' records.
The serological tests for our patients were done by the Centers for Disease Control and Prevention by means of an indirect fluorescent antibody technique; either Ehrlichia canis (from 1989 to 1991) or E. chaffeensis (1992, onwards) was used as the antigen. PCR analysis was done as previously described [5] .
For the purposes of this report, a confirmed diagnosis of ehrlichiosis was defined as a clinical illness compatible with the infection, accompanied by a fourfold increase or decrease in titers of antibodies to E. canis or E. chaffeensis; visualization of morulae; a positive PCR result with use of E. chaffeensis primers; or all three. The cases from the literature had been confirmed serologically by visualization of morulae, by PCR analysis with use of E. chaffeensis or HGE primers, or by all methods.
Results
Fifteen of fifty-seven patients with ehrlichiosis presented to our hospitals with symptoms or signs suggestive of neurological involvement, which prompted examination of CSF samples and other studies of the CNS. The CSF findings were abnormal for eight of these patients. Twenty-one additional patients whose cases were reported in the literature had CSF samples examined. Thirteen of these patients had abnormal CSF findings.
The demographics and CNS symptoms and signs for all 21 patients with abnormal CSF findings are shown in table 1; all of the patients, except patient 5, were infected with E. chaffeensis [8] [9] [10] [11] [12] [13] [14] . Of the 15 patients with normal CSF findings, nine were infected with E. chaffeensis, and six were infected with the agent of HGE [5, 8, 16, 17] . Of the nine patients infected with E. chaffeensis, eight had fever (temperature, ;:::38°C) and intense headache as the primary symptoms, prompting lumbar puncture. Only one patient had confusion; however, this patient had Alzheimer's disease. Of the six patients with HGE, one had fever, confusion, and ataxia, one had fever and was somnolent, and four had' 'neurologic symptoms other than headache" that were not further specified [5, 17] .
Patient 1 is noteworthy in that she developed delirium on the fifth day of illness, which cleared after an 8-day course of therapy with doxycycline. One month after the completion of 14 days of doxycycline therapy, this patient was readmitted to the hospital with central seventh nerve palsy.
The results of the patients' CSF examinations are summarized in table 1. Of nineteen patients with CSF pleocytosis, 73% manifested lymphocytosis, and neutrophils predominated in the CSF of 23% of the patients. Two patients (patients 9 and 12) had only one WBC in the CSF, but they had elevated protein levels. Borderline hypoglycorrhachia was present in five patients. Morulae were observed only in the CSF granulocytes of one of our eight patients (patient 5) (figure 1). Morulae were visualized in CSF mononuclear cells of one additional patient who was found to be positive for E. chaffeensis DNA by PCR analysis [12] . CSF samples from five patients were tested by PCR with E. chaffeensis primers, and the CSF was positive in two of five cases. For patient 5, PCR analysis was positive with Ehrlichia genus primers EC19 and EC20 but it was negative with E. chaffeensis primers HE-l and HE-3 [3] .
The results of serial CSF studies were available for one of our patients (patient 1). Lumbar punctures were done for this patient on days 13, 50, 53, 60, and 68 of illness. The studies showed the persistence of lymphocytic pleocytosis and an elevated protein level. Her last CSF studies showed a protein level of 2.46 giL and a WBC count that had declined from a peak of 81 X 106/L to 20 X 10 6 /L, with 94% lymphocytes. She developed facial nerve palsy after treatment for ehrlichiosis; in addition, an EIA for Borrelia burgdorferi in serum and CSF yielded an equivocal result, and CSF study results remained abnormal. Therefore, she received a course of treatment with ceftriaxone for possible Lyme disease.
Patient 15 had a repeated lumbar puncture done at an unspecified period after the initial procedure was done. Examination of the CSF obtained during the second lumbar puncture showed a decrease in the WBC count from 1,200 X 10 6 IL to 750 X 10 6/L. The protein level remained elevated at 0.82 giL. Patient 17 underwent a repeated lumbar puncture 1 day after the initial procedure, and examination of the CSF showed an increase in the WBC count from 56 X 106/L to 225 X 106/L, with 72% neutrophils and 28% lymphocytes. Patient 18 underwent repeated studies 10 days after the initial CSF examination; a decrease in the WBC count from 160 X 10 6 IL to lOx 10 6 IL was observed. Patient 19 had repeated studies done 9 days after the initial study, and these studies yielded the same results as did the previous examination (WBC count, 14 X 10 6 IL, with normal levels of protein and glucose).
Results of head CT scans (five of which were performed with contrast media) were available for 11 of our patients and three of the patients described in the literature [1, 5, 13] . None of the scans showed abnormalities. A gadolinium-enhanced study was done for one patient (patient 8) and showed enhancement of the meninges, a finding consistent with meningitis. The electroencephalograms of patients 1, 4, and 21 showed diffuse slowing, consistent with encephalopathy.
Seventeen of the 21 patients survived their illnesses. Only patient 1 developed a focal neurological deficit, which resolved over 6 months after she recovered. The conditions of 14 survivors for whom histories were available improved~4 days after doxycycline therapy was started. Patient 9 was noted to have confusion for 30 days despite treatment with chloramphenicol and doxycycline.
Four of the 21 patients died. Patient 4, who was treated at our institution, died of various complications including candidemia. Autopsy revealed no specific findings in the CNS. The other three patients also died after prolonged illnesses with numerous complications typical of patients treated in the intensive care unit. The autopsy report for patient 20 contained no CNS findings.
Discussion
Human ehrlichia infections are becoming increasingly common in the United States. Most of the reported cases have come from the southeastern and south central states and have been caused by E. chaffeensis. It is now apparent that the geographic area where these infections occur is expanding and that more than one Ehrlichia species may cause disease [5, 15, 18, 19] . Illness produced by Ehrlichia is nonspecific and requires a high index of suspicion for diagnosis.
On the basis of our assessment of our cases and those in the literature, it is apparent that CNS findings, in addition to hematologic and hepatic involvement, are relatively common in patients with ehrlichiosis. Manifestations include severe headache, confusion, lethargy, broad-based gait, hyperreflexia, cm 1996;23 (August) Figure 1 . Composite photograph of a Wright-Giemsa stain of a cytospin of CSF from a patientwith ehrlichiosis (patient 5) showing morulae (arrows) in the cytoplasm of granulocytes (original magnification, X 1,000).
clonus, photophobia, cranial nerve palsy, seizures, blurred vision, nuchal rigidity, and ataxia. Such findings have prompted studies, namely CSF examinations and CT brain scans, in an attempt to elucidate their causes. Thus far the majority of patients (20 of 21) whose CSF findings have been abnormal have been infected with E. chaffeensis; an exception is patient 5, who is believed to have had HGE. Whether this finding reflects the number of cases studied or the fact that E. chaffeensis is more neurotrophic than other Ehrlichia species is unclear. When patients with abnormal CSF are compared with those whose CSF is normal, the clinical finding that has been most predictive of abnormal CSF is mental status changes. In contrast, the small number of patients evaluated who were infected with the agent of HGE, some of whom had mental status changes, did not have CSF abnormalities.
For this series of patients with ehrlichiosis, the most common CSF abnormalities were lymphocytic pleocytosis (73% of patients) and elevated protein values (76%). Twenty-four percent had borderline low CSF glucose concentrations. These findings are nonspecific, but they could easily be confused clinically with those of bacterial meningitis or partially treated bacterial meningitis or viral, fungal, or mycobacterial meningitis unless the primary diagnosis of ehrlichiosis is considered. Furthermore, failure to consider the appropriate diagnosis would likely lead to therapy with drugs not known to be effective against Ehrlichia species.
The likelihood that the diagnosis of ehrlichia meningitis will be confirmed by examination of the CSF appears to be small. In only two cases (patients 5 and 18) were morulae seen in cells in the CSF. The fact that morulae were detected so infrequently may be due to the low numbers of organisms present or that most routine examinations of CSF do not include WrightGiemsa stains, which are necessary to visualize the organisms. Analysis of the CSF by PCR may offer some promise in that one patient (patient 18) described in the literature and two of our patients were found to be positive for Ehrlichia DNA when E. chaffeensis primers were used in the analysis.
The radiological and encephalographic studies performed for all of the patients failed to show lesions that aided in any specific diagnosis. Nevertheless, we believe that these studies may be of value in that they help to eliminate diagnoses such as subdural empyema, brain abscess, and focal viral encephalitis, which may produce similar clinical findings and CSF abnormalities.
There are few data available on the CNS pathology associated with ehrlichia infections. One of our patients (patient 4) with severe encephalopathy, minimal CSF pleocytosis, and an elevated CSF protein level had no gross or microscopic changes in his meninges or brain. Patient 20 also had no CNS lesions reported at autopsy. One other patient was described as having perivascular cuffing and plasma cells in the brain tissue [20] .
The mortality associated with human ehrlichia infections is not well established. In one series of patients described by Fishbein et al. [7] three (1.3%) of237 patients died; we believe this number included the two deaths among 40 patients described earlier by Eng et al. [14] . Both patients who died had CNS involvement and are included in this report (patients 20 and 21). Of our 57 patients, two (3.5%) have died, including patient 4 in this report. Bakken et al. [5] reported that two (4.9%) of 41 patients with HGE who presumably did not have CNS disease died. Overall, four (19%) of 21 patients reported herein who had CNS manifestations and abnormal CSF died. On reviewing these cases, we concluded that death resulted from severe systemic illness rather than from CNS involvement itself.
Patients with CNS manifestations of ehrlichiosis and abnormal CSF findings were often treated with multiple antimicrobial agents, but all received chloramphenicol, a tetracycline, or a combination of both drugs sometime during their illness. The day of illness when definitive therapy was begun varied between day 6 and day 22 for those who lived and between day 7 and day 12 for those that died. Nine of 14 survivors for whom data were available showed improvement of mental status within~4 days after treatment was begun. Patient 9 was noted to have confusion for 30 days despite treatment with chloramphenicol and doxycycline. There are insufficient data regarding the resolution of CSF abnormalities, but in one of our cases (patient 1), abnormal CSF values were present for 68 days after the onset of illness.
In summary, CNS manifestations are relatively common in human ehrlichia infections. Associated objective evidence of CSF pleocytosis (usually lymphocytic pleocytosis with an elevated protein level) is well documented in E. chaffeensis infections but may occur less frequently in patients with HGE. Among patients with E. chaffeensis infections, the presence of mental status changes was the clinical finding most predictive of abnormal CSF findings. The clinical course for those with CNS abnormalities was variable, and no correlation between outcome and underlying illnesses or day of illness when therapy was instituted was identified. Nineteen percent of patients with CNS manifestations and abnormal CSF findings have died.
